Scholarly Journals In Immunhistochemistry
Immunohistochemistry (IHC) is a method to identify specific antigens within tissue sections utilizing an antigen-specific antibody. Detection at the light microscopic level of antigen–antibody interactions can be achieved by labeling the antibody with a substance that can be visualized, either by conjugation to a
fluorescent marker or enzyme followed by colorimetric detection. Immunologic detection of antigens dates to the early 20th century when Marrack demonstrated that anti-typhoid and anti-cholera sera-labeled with diazotized benzidine-azo-r-salt imparted a red color to the bacteria. Although groundbreaking for immunological detection of antigens, Coons determined this labeling method to be relatively insensitive when applied to tissues, and subsequently described assays utilizing fluorescent-labeled antibodies in fixed tissues, but interpretation was confounded by the enhanced endogenous fluorescent activity in formalin-fixed tissue. In 1966, Nakane described a method of antigen detection in tissue using an antibody conjugated to an enzyme (horseradish peroxidase) and utilized a colorimetric substrate that could be detected by light microscopy, which is the theoretical basis of most modern tissue-based immunohistochemical assays. This chapter will focus on detection of
rabies virus (RABV) antigens in formalin-fixed, paraffin-embedded (FFPE) tissues. The materials and methods describe a single protocol. However, the reader is encouraged to investigate the many alternative non-proprietary and proprietary protocols that are also available. Detection of antigens in FFPE
tissues presents a unique diagnostic challenge regarding validation of the assay and interpretation of the results.
High Impact List of Articles
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical